Holen Sie sich die Stockscreener-App
10.71
0.09%
0.01
Schlusskurs vom Vortag:
$10.70
Offen:
$10.71
24-Stunden-Volumen:
10,022
Relative Volume:
0.18
Marktkapitalisierung:
$260.01M
Einnahmen:
-
Nettoeinkommen (Verlust:
$6.66M
KGV:
54.04
EPS:
0.1982
Netto-Cashflow:
$-379.20K
1W Leistung:
+0.09%
1M Leistung:
+0.66%
6M Leistung:
+2.88%
1J Leistung:
+4.34%
1-Tages-Spanne:
$10.71
$10.71
1-Wochen-Bereich:
$10.66
$10.72
52-Wochen-Spanne:
$10.22
$10.72
Drugs Made In America Acquisition Corp Stock (DMAA) Company Profile
Firmenname
Drugs Made In America Acquisition Corp
Sektor
Branche
Telefon
646-726-7074
Adresse
420 LEXINGTON AVENUE, NEW YORK
Compare DMAA vs LION, XXI, UMAC, CCXI, DMII
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DMAA
Drugs Made In America Acquisition Corp
|
10.71 | 259.76M | 0 | 6.66M | -379.20K | 0.1982 |
LION
Lionsgate Studios Corp
|
13.25 | 3.86B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
4.40 | 1.57B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
19.92 | 984.55M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
14.52 | 764.20M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.11 | 643.69M | 0 | 8.58M | -1.11M | 0.134 |
Drugs Made In America Acquisition Corp Aktie (DMAA) Neueste Nachrichten
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.105|Chg%:+0.005 - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.709|Chg%:+0.009 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Cash Flow - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMIIR - TradingView
Drugs Made In America Acquisition Corp (DMAA) Institutional Confidence - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition Corp - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Institutional Confidence - TradingKey
Drugs Made In America Acquisition II Ord Shs - TradingKey
162,795 Shares in Drugs Made In America Acquisition Corp. $DMAA Purchased by Sona Asset Management US LLC - MarketBeat
DMII|Drugs Made In America Acquisition II Ord Shs|Price:10.100|Chg%:-0.005 - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Valuation: PE, PB & Fair Value Analysis - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
Drugs Made In America Acquisition Corp (DMAA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Drugs Made In America Acquisition II Corp. Revenue Breakdown – NASDAQ:DMII - TradingView
TradingKey - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Balance Sheet - TradingKey
Drugs Made In America Acquisition II Ord Shs (DMII) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Cash Flow - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.700|Chg%:-0.020 - TradingKey
Drugs Made In America Acquisition Corp (DMAA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
DMAA|Drugs Made In America Acquisition Corp|Price:10.700| - TradingKey
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Drugs Made In America Acquisition Corp. (NASDAQ: DMAA) - PR Newswire
Drugs Made In America (NASDAQ: DMAA) tightens PAGC merger terms and sponsor economics - Stock Titan
Drugs Made In America amends merger agreement terms - TipRanks
Drugs Made In America Acquisition Revises PAGC Merger; Sets $30M Target Cash and Founder Share Forfeiture - TradingView
Pfizer Inc. | Pharmaceuticals, Vaccines & Company History | Britannica Money - Encyclopedia Britannica
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Price to earnings forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Price to sales forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Enterprise value to EBIT forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAA - TradingView
Enterprise value to revenue forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
Enterprise value to EBIT forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
Drugs Made In America Acquisition Corp. Rights (DMAAR) Hold Steady at $0.10 Amid Low ActivityRetail Sentiment - dars.gov.et
Drugs Made In America Acquisition (NASDAQ:DMAA) Trading Down 0.1%Here's What Happened - MarketBeat
Eli Lilly and Co. | Pharmaceuticals, Biomedical Research, & Company - Encyclopedia Britannica
Price to sales forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Price to earnings forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
HSLV Q2 2026 Earnings: Massive EPS Surprise Despite No Reported RevenueCFO Commentary Report - dars.gov.et
Enterprise value to EBIT forward of Drugs Made In America Acquisition II Corp. – BOATS:DMIIU - TradingView
Enterprise value to EBITDA forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
Price to book forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAU - TradingView
OACCU Stock Fund Price and Chart — NASDAQ:OACCU - TradingView
Drugs Made In America Acquisition Corp. Rights (DMAAR) Edges Higher in Thin TradingDouble EMA - dars.gov.et
Price to sales forward of Drugs Made In America Acquisition Corp. – NASDAQ:DMAAR - TradingView
NTWO PE Ratio & Valuation, Is NTWO Overvalued - Intellectia AI
Finanzdaten der Drugs Made In America Acquisition Corp-Aktie (DMAA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.83%
0.19%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):